Gaurav Shah
Known title: CEOCIK: 0001725922
Gaurav Shah's purchase track record
Gaurav Shah has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/10/2025 | RCKT | $102K | -36.0% | -25.7% | +27.9% |
| 2/7/2022 | RCKT | $382K | -52.7% | -9.3% | -7.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| RCKT | ▼ Sell | Open Market | 2,293 | $8K | 8/18/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 2,837 | $10K | 8/13/2026 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 76,490 | $129K | 5/21/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 55,684 | $172K | 5/21/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 2,409 | $7K | 5/19/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 2,728 | $10K | 5/13/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 5,990 | $20K | 2/18/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 12,279 | $41K | 2/13/2026 | View on chart |
| RCKT | ▲ Buy | Grant | 286,028 | $0 | 2/11/2026 | View on chart |
| RCKT | ▼ Sell | Open Market | 6,276 | $19K | 11/18/2025 | View on chart |
| RCKT | ▼ Sell | Tax Withholding | 2,234 | $7K | 8/18/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 2,253 | $15K | 5/20/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 3,621 | $24K | 5/16/2025 | View on chart |
| RCKT | ▲ Buy | Open Market | 20,000 | $102K | 4/10/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 16,303 | $172K | 2/21/2025 | View on chart |
| RCKT | ▲ Buy | Grant | 81,655 | $0 | 2/11/2025 | View on chart |
| RCKT | ▼ Sell | Open Market | 11,091 | $145K | 11/21/2024 | View on chart |
| RCKT | ▼ Sell | Open Market | 9,650 | $179K | 8/16/2024 | View on chart |
| RCKT | ▼ Sell | Open Market | 9,790 | $229K | 5/16/2024 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 7,979 | $0 | 5/14/2024 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 9,683 | $0 | 5/14/2024 | View on chart |
| RCKT | ▼ Sell | Open Market | 20,272 | $605K | 2/16/2024 | View on chart |
| RCKT | ▲ Buy | Grant | 66,577 | $0 | 2/16/2024 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 46,828 | $0 | 2/14/2024 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 7,979 | $0 | 11/14/2023 | View on chart |
| RCKT | ▼ Sell | Open Market | 4,767 | $74K | 8/17/2023 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 7,979 | $0 | 8/14/2023 | View on chart |
| RCKT | ▼ Sell | Open Market | 4,122 | $88K | 5/17/2023 | View on chart |
| RCKT | ▲ Buy | Option Exercise | 7,979 | $0 | 5/14/2023 | View on chart |
| RCKT | ▼ Sell | Open Market | 12,194 | $232K | 2/17/2023 | View on chart |
| RCKT | ▼ Sell | Other | 67,785 | $0 | 2/14/2023 | View on chart |
| RCKT | ▼ Sell | Other | 23,940 | $0 | 2/14/2022 | View on chart |
| RCKT | ▲ Buy | Open Market | 22,000 | $382K | 2/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Rocket Pharmaceuticals Gets FDA Alignment on Heart Drug Trial
Rocket Pharmaceuticals has secured FDA alignment on a trial for its heart drug, which may help address prior safety concerns. This regulatory step is significant for the company's development timeline. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite this progress.
Rocket Pharmaceuticals Gets FDA Alignment on Heart Drug Trial. Rocket Pharmaceuticals has secured FDA alignment on a trial for its heart drug, which may help address prior safety concerns. This regulatory step is significant for the company's development timeline. The stock is currently trading near its 52-week low, reflecting ongoing market caution despite this progress.